Nephrogenic Systemic Fibrosis Risk and Liver Disease

Table 4

Table 4 demonstrates the association of NSF in patients with liver disease and varying degrees of renal failure. The mild to moderate renal group that the Gd warning label targets had 0 cases of NSF.

Characteristics	Patients	NSF cases
Liver + no renal disease	183 (58.8%)	0 (0%)
Liver + mild/mod. renal (GFR 30–90) Dz	106 (34.3%)	0 (0%)
Liver + severe renal Dz (GFR < 30)	21 (6.9%)	2 (100%)
Total	310	2